Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001823239-26-000059
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Net cash provided by (used in) operating activities | 12,657 | (19,655) |
| Investing activities: | ||
| Cash paid for acquisitions of a business, net of cash acquired | — | (18,990) |
| Purchases of property and equipment | (4,807) | (7,375) |
| Net cash used in investing activities | (4,807) | (26,365) |
| Financing activities: | ||
| Proceeds from borrowings of long-term debt | 150,000 | — |
| Principal repayments of long-term debt | (294,240) | (2,720) |
Item 1. Financial Statements
FAQ
- What is Maravai LifeSciences Holdings, Inc.'s capex?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported capex of $370K in Q2 2026.
- How has Maravai LifeSciences Holdings, Inc.'s capex changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s capex decreased by 87.1% year-over-year, from $2.87M to $370K.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s capex?
- Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s capex has grown at a -3.0% compound annual growth rate (CAGR), from $14.85M to $13.15M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Maravai LifeSciences Holdings, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude